Tag Archives: ‘vaccine

COVID Cases, Deaths Plummet in Nursing Homes After Vaccine Rollout

THURSDAY, Feb. 25, 2021 — In a hopeful turnaround during a long pandemic, U.S. nursing homes that were once the epicenter of coronavirus infections are now seeing both cases and deaths fall steeply as the country’s vaccination rollout starts to take hold. From late December to early February, new cases among U.S. nursing home residents… Read More »

Most Americans probably won’t be able to get a Covid-19 vaccine until mid-2021, CDC director says

“Those who are vaccine hesitant have had their hesitancy enhanced by a variety of things that are happening right now, particularly the unfortunate mix of science and politics,” Collins said at an event hosted by the National Academies of Sciences, Engineering and Medicine. A recent poll from the Kaiser Family Foundation found that more than… Read More »

Australia’s big vaccine advantage

Scott Morrison says Australia won’t be “completely hostage” to overseas vaccine schedules once it begins to manufacture the AstraZeneca jab onshore. The Therapeutic Goods Administration (TGA) on Monday granted the Pfizer vaccine provisional approval for use in Australia, the first COVID-19 vaccine Supply issues have hampered the delivery of the jab across Europe, and the… Read More »

Apps Now Being Developed for Global Vaccine Passport

Vaccine passports, hastily ushered in as a byproduct of the COVID-19 pandemic, are expected to become “widely available” during the first half of 2021. “Rest assured, the nerds are on it,” Brian Behlendorf, executive director of Linux Foundation, told CNN Business.1 The Linux Foundation has partnered with IBM, the COVID-19 Credentials Initiative and CommonPass, a… Read More »

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

COVID-19 Vaccine Trial Paused Due to Adverse Event

UPDATE: The trial of the AZD1222 vaccine in the U.K. has already resumed after an independent investigation by the Medicines Health Regulatory Authority concluded it was safe to proceed. “AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials,” the company said in a September 12 press release.… Read More »

AstraZeneca to resume vaccine trials after ‘potentially unexplained illness’ prompted pause

AstraZeneca announced that it was restarting phase three coronavirus vaccine trials after they were paused when a participant became ill. The pharmaceutical giant announced the resumption on Saturday after the trials were put on hold on Sunday. The patient in question, a woman, was from the United Kingdom and reportedly suffered a rare spinal cord… Read More »